-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JeU+0y2N4uRXk4Axtzph5KakSN1wTLc2KUi8AIQZOh4fk8nEdjofz3QQJ7JrtEn6 qhmykGnBzhEuUAGVizur4A== 0001104659-08-054666.txt : 20080822 0001104659-08-054666.hdr.sgml : 20080822 20080822163406 ACCESSION NUMBER: 0001104659-08-054666 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080822 DATE AS OF CHANGE: 20080822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-114038 FILM NUMBER: 081034910 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 POS AM 1 a08-22170_2posam.htm POS AM

 

As filed with the Securities and Exchange Commission on  August 22, 2008

Registration No. 333-114038

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

POST-EFFECTIVE AMENDMENT NO. 1

 

TO

 

FORM S-3

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 


 

Hanger Orthopedic Group, Inc.

(Exact name of Registrant as specified in its charter)

 

 

 

Two Bethesda Metro Center, Suite 1200

 

 

 

 

Bethesda, Maryland 20814

 

 

Delaware

 

(301) 986-0701

 

84-0904275

(State of other jurisdiction of

 

(Address, including zip code, and

 

(IRS Employer

incorporation or organization)

 

telephone number, including area code,

 

(Identification No.)

 

 

of registrant’s principal executive offices)

 

 

 


 

Thomas F. Kirk

President and Chief Executive Officer

Hanger Orthopedic Group, Inc.

Two Bethesda Metro Center, Suite 1200

Bethesda, Maryland 20814

(Name, address and telephone number, of agent for service)

 

with a copy to:

 

Thomas E. Hartman, Esq.

Foley & Lardner LLP

500 Woodward Avenue, Suite 2700

Detroit, Michigan 48226

(313) 234-7100

 

Approximate date of commencement of proposed sale to the public: Not applicable.

 


 

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, please check the following box. o

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) of the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. o

 

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

 

Accelerated filer x

 

 

 

Non-accelerated filer o  (Do not check if a smaller reporting company)

Smaller reporting company o

 


 

 

 



 

DEREGISTRATION OF SECURITIES

 

This post-effective Amendment No. 1 to the Registration Statement on Form S-3 (Registration No. 333-114038) of the Registrant filed with the Securities and Exchange Commission on March 30, 2004 (the “Registration Statement”) hereby amends the Registration Statement to deregister all of the securities registered pursuant to the Registration Statement, none of which were sold thereunder.

 

In accordance with the Registrant’s undertaking in Part II, Item 17.A.(3) of the Registration Statement, the Registrant is deregistering by means of this post-effective amendment any securities remaining unsold thereunder.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this post-effective amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bethesda, State of Maryland, on August 22, 2008.

 

HANGER ORTHOPEDIC GROUP, INC.

 

By:

/s/ George E. McHenry

 

George E. McHenry

 Executive Vice President and Chief Financial Officer

 

Pursuant to the requirements of the Securities Act of 1933, this post-effective amendment to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

BY:

/s/ Thomas F. Kirk

 

President, Chief Executive Officer

 

August 22, 2008

 

Thomas F. Kirk

 

and Director

 

 

 

 

(Principal Executive Officer)

 

 

 

 

 

 

 

 

/s/ George E. McHenry

 

Executive Vice President and

 

August 22, 2008

 

George E. McHenry

 

Chief Financial Officer

 

 

 

 

(Principal Financial Officer)

 

 

 

 

 

 

 

 

/s/ Thomas C. Hofmeister

 

Vice President – Finance and

 

August 22, 2008

 

Thomas C. Hofmeister

 

Chief Accounting Officer

 

 

 

 

(Principal Accounting Officer)

 

 

 

 

 

 

 

BY:

/s/ George E. McHenry

 

Chairman of the Board

 

August 22, 2008

 

Attorney-in-Fact

 

and Director

 

 

 

Ivan R. Sabel

 

 

 

 

 

 

 

 

 

BY:

/s/ George E. McHenry

 

Director

 

August 22, 2008

 

Attorney-in-Fact

 

 

 

 

 

Edmond E. Charrette

 

 

 

 

 

 

 

 

 

BY:

/s/ George E. McHenry

 

Director

 

August 22, 2008

 

Attorney-in-Fact

 

 

 

 

 

Thomas P. Cooper, M.D.

 

 

 

 

 

 

 

 

 

BY:

/s/ George E. McHenry

 

Director

 

August 22, 2008

 

Attorney-in-Fact

 

 

 

 

 

Eric A. Green

 

 

 

 

 

3



 

BY:

/s/ George E. McHenry

 

Director

 

August 22, 2008

 

Attorney-in-Fact

 

 

 

 

 

Cynthia L. Feldmann

 

 

 

 

 

 

 

 

 

BY:

/s/ George E. McHenry

 

Director

 

August 22, 2008

 

Attorney-in-Fact

 

 

 

 

 

H.E. Thranhardt, CPO

 

 

 

 

 

4


GRAPHIC 3 g221702bei001.gif GRAPHIC begin 644 g221702bei001.gif M1TE&.#EAC@`V`'<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"'Y M!`$`````+`$``0",`#0`@`````````+_C(\(R^EOF&QNVE6OACSBI%E=)X[0 M908AD*U2VCXN"[=4?91I:,]X?@.N*C#=;W)$@6;!VJN').ZB/U6S:/0P:I]*?8%P>H MAJ@4*;C!%QC)-?>GN/B%245(*4F8:-.SF4E::0FJRN@Z.=4(J=IJ*/J6 MF,N8Z\AY:PB+N.O;VUJ87/QWG'KW#$?B8L*\ZAS;MWV).BH];(U7O08./2)K M[H/#36ZL;4>]KCZ?_CGM>9\LOX#B!U]I]XV`G7+U9_0X61(9-WJ.% MQ!(.I/C08#PH__\P>@H%#V)&4:@ZNFL(3:3'C"F;212FSV4G<_0B=FID\EPI M/3EIAE0H,YC.;K18^;R7C&2MB?K$`=O'::G-CR^'[G1RT*D_K5.#]JR)-2O4 MK6.[VA2:LZFV*CBY.O3*L2;`D_:ZR&2)-Z_>O7S[^OT+.+#@P80+&SZ,.+'B MQ8P;.WX,.;+DR90K6[Z,.;/FS9P[>_ZS0IPXKBEFXZ]&_L+ MUBU9;,_>1$RQY[&C@T]>785P3=2U*Z<>8[EWU=>-S#=>HKGK]GZJATK_[QYX MJ=Q77W_?@+NAIY\"+96T87W.6CA;Q).IYUN ;,QTXX2!R[.=A/BN&>!UPQ(#8G8&D#6A(`0`[ ` end
-----END PRIVACY-ENHANCED MESSAGE-----